Stocks Health care SNDX

NASDAQ · Health care

Syndax Pharmaceuticals Inc (SNDX)

Syndax Pharmaceuticals Inc brought in $252M of revenue over the twelve months to June 30, 2026, up 222.3% from a year earlier. It posted a net loss of $220.8M. In fiscal 2025 capital spending exceeded operating cash flow by $323.2M. At June 30, 2026 it held $336.5M in cash against $350M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 4, 2026.

What Syndax Pharmaceuticals Inc does

Syndax Pharmaceuticals Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SNDX.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Where SNDX ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Syndax Pharmaceuticals Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 4, 2026
   Quarterly report 10-Q · period to June 30, 2026
2. August 4, 2026
   Quarterly results 8-K
3. July 14, 2026
   Other event 8-K
4. June 10, 2026
   Material agreement 8-K
5. June 10, 2026
   Executive or director change 8-K
6. June 4, 2026
   Additional proxy material DEFA14A
7. June 4, 2026
   Material agreement 8-K
8. May 15, 2026
   Passive stake changed SCHEDULE 13G/A
9. April 30, 2026
   Annual report to shareholders ARS
10. April 30, 2026
    Additional proxy material DEFA14A

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 9, 2026. Insider transactions on SEC

Insider trades

What the people running Syndax Pharmaceuticals Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about SNDX

What does Syndax Pharmaceuticals Inc do?

Syndax Pharmaceuticals Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SNDX.

Is Syndax Pharmaceuticals Inc profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $220.8M on revenue of $252M.

How much revenue does Syndax Pharmaceuticals Inc make?

Over the twelve months to June 30, 2026 Syndax Pharmaceuticals Inc reported revenue of $252M. That is 222.3% more than a year earlier.

When did Syndax Pharmaceuticals Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 4, 2026. It covers the period to June 30, 2026.

Similar companies

Compare SNDX with

Compare SNDX with any company

Follow SNDX

Get an email when Syndax Pharmaceuticals Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow SNDX: get an email when it files

Where the numbers come from

Financial figures are the values Syndax Pharmaceuticals Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.